BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 35091321)

  • 1. Effect of perioperative probiotic supplements on postoperative short-term outcomes in gastric cancer patients receiving neoadjuvant chemotherapy: A double-blind, randomized controlled trial.
    Liu G; Cao S; Liu X; Li Z; Tian Y; Zhang X; Zhong H; Zhou Y
    Nutrition; 2022 Apr; 96():111574. PubMed ID: 35091321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Risk factors of postoperative complication after total gastrectomy in advanced gastric cancer patients receiving neoadjuvant chemotherapy].
    Cui H; Zhang KC; Cao B; Deng H; Liu GX; Cui JX; Xie TY; Liang WQ; Zhang QP; Wang N; Chen L; Wei B
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb; 24(2):153-159. PubMed ID: 33508921
    [No Abstract]   [Full Text] [Related]  

  • 3. The influence of neoadjuvant chemotherapy on gastric cancer patients' postoperative infectious complications: What is the negative role played by the intestinal barrier dysfunction?
    Wei Z; Tan B; Cao S; Liu S; Tan X; Yao Z; Yin N; Li J; Zhang D; Zhou Y
    Oncotarget; 2017 Jun; 8(26):43376-43388. PubMed ID: 28118611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of totally laparoscopic and laparoscopic assisted gastrectomy after neoadjuvant chemotherapy in locally advanced gastric cancer.
    Xing J; Wang Y; Shan F; Li S; Jia Y; Ying X; Zhang Y; Li Z; Ji J
    Eur J Surg Oncol; 2021 Aug; 47(8):2023-2030. PubMed ID: 33663942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of Laparoscopic Distal Gastrectomy After Neoadjuvant Chemotherapy for Locally Advanced Gastric Cancer: A Randomized Clinical Trial.
    Li Z; Shan F; Ying X; Zhang Y; E JY; Wang Y; Ren H; Su X; Ji J
    JAMA Surg; 2019 Dec; 154(12):1093-1101. PubMed ID: 31553463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparative analysis on clinical efficacy of FOLFOX6 regimen and DCF regimen as neoadjuvant chemotherapy combined with radical gastrectomy in treating advanced gastric cancer.
    Tai Q; Shao H; Liu Y; Li E; Zhao R
    J BUON; 2019; 24(5):2006-2012. PubMed ID: 31786868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Feasibility research of enhanced recovery after surgery implemented in esophageal cancer patients who underwent neoadjuvant chemotherapy.
    Tang Z; Zhu X; Li Y; Qu C; Li L; Li S; Qi L; Lu M; Cheng C; Tian H
    World J Surg Oncol; 2022 Jul; 20(1):239. PubMed ID: 35879767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of neoadjuvant chemotherapy on surgical and pathological results of gastric cancer patients: A case-control study.
    Charruf AZ; Ramos MFKP; Pereira MA; Dias AR; de Castria TB; Zilberstein B; Cecconelo I; Ribeiro U
    J Surg Oncol; 2020 Apr; 121(5):833-839. PubMed ID: 31943232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A multi-center retrospective study of perioperative chemotherapy for gastric cancer based on real-world data].
    Ding XW; Zheng ZC; Zhao Q; Zhai G; Liang H; Wu X; Zhu ZG; Wang HJ; He QS; He XL; Du YA; Chen LC; Hua YW; Huang CM; Xue YW; Zhou Y; Zhou YB; Wu D; Fang XD; Dai YG; Zhang HW; Cao JQ; Li LP; Chai J; Tao KX; Li GL; Jie ZG; Ge J; Xu ZF; Zhang WB; Li QY; Zhao P; Ma ZQ; Yan ZL; Zheng GL; Yan Y; Tang XL; Zhou X
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 May; 24(5):403-412. PubMed ID: 34000769
    [No Abstract]   [Full Text] [Related]  

  • 10. [Safety and effectiveness of oxaliplatin combined with capecitabine or oxaliplatin combined with S-1 neoadjuvant chemotherapy in the treatment of advanced gastric cancer].
    Xie BW; Zang L; Ma JJ; Sun J; Yang X; Wang ML; Lu AG; Hu WG; Zheng MH
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb; 24(2):138-144. PubMed ID: 33508919
    [No Abstract]   [Full Text] [Related]  

  • 11. Radical Gastrectomy: Still the Cornerstone of Curative Treatment for Gastric Cancer in the Perioperative Chemotherapy Era-A Single Institute Experience over a Decade.
    Kanhere H; Goel R; Finlay B; Trochsler M; Maddern G
    Int J Surg Oncol; 2018; 2018():9371492. PubMed ID: 29568650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neoadjuvant chemotherapy in advanced gastric and esophago-gastric cancer. Meta-analysis of randomized trials.
    Coccolini F; Nardi M; Montori G; Ceresoli M; Celotti A; Cascinu S; Fugazzola P; Tomasoni M; Glehen O; Catena F; Yonemura Y; Ansaloni L
    Int J Surg; 2018 Mar; 51():120-127. PubMed ID: 29413875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parenteral nutrition during neoadjuvant chemotherapy for patients with non-metastatic gastric or esophago-gastric cancer to reduce postoperative morbidity (PERCOG): study protocol for a randomized controlled trial.
    Mueller TC; Schirren R; Kehl V; Friess H; Reim D; Martignoni ME
    Trials; 2017 Dec; 18(1):621. PubMed ID: 29282145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The safety and efficacy of laparoscopic gastrectomy for patients with locally advanced gastric cancer following neoadjuvant chemotherapy.
    Liu L; Wang C; Li F; Zhang X; Cheng X; Lin S; Liu Y; Yang C; Li W
    Sci Rep; 2022 Jun; 12(1):10384. PubMed ID: 35726012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival outcome and perioperative complication related to neoadjuvant chemotherapy with carboplatin and paclitaxel for advanced ovarian cancer: A systematic review and meta-analysis.
    Machida H; Tokunaga H; Matsuo K; Matsumura N; Kobayashi Y; Tabata T; Kaneuchi M; Nagase S; Mikami M
    Eur J Surg Oncol; 2020 May; 46(5):868-875. PubMed ID: 31818526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A systematic review and meta-analysis on the effect of neoadjuvant chemotherapy on complications following immediate breast reconstruction.
    Varghese J; Gohari SS; Rizki H; Faheem M; Langridge B; Kümmel S; Johnson L; Schmid P
    Breast; 2021 Feb; 55():55-62. PubMed ID: 33341706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neoadjuvant chemotherapy does not disproportionately influence post-operative complication rates or time to chemotherapy in obese patients with advanced-stage ovarian cancer.
    Kanbergs AN; Manning-Geist BL; Pelletier A; Sullivan MW; Del Carmen MG; Horowitz NS; Growdon WB; Clark RM; Muto MG; Worley MJ
    Gynecol Oncol; 2020 Dec; 159(3):687-691. PubMed ID: 32951891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Analysis of factors related to the prognostic benefit of neoadjuvant chemotherapy followed by interval debulking surgery in patients with advanced ovarian cancer].
    Wang DF; Zhang GN; Peng CR; Shi Y; Shi XW
    Zhonghua Fu Chan Ke Za Zhi; 2021 Jun; 56(6):385-392. PubMed ID: 34154313
    [No Abstract]   [Full Text] [Related]  

  • 19. Impact of postoperative infectious complications on adjuvant chemotherapy administration after gastrectomy for advanced gastric cancer.
    Tsujimoto H; Kouzu K; Sugasawa H; Nomura S; Ito N; Harada M; Sugihara T; Ishibashi Y; Kishi Y; Ueno H
    Jpn J Clin Oncol; 2021 Mar; 51(3):379-386. PubMed ID: 33236062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complications after radical gastrectomy following FOLFOX7 neoadjuvant chemotherapy for gastric cancer.
    Li ZY; Shan F; Zhang LH; Bu ZD; Wu AW; Wu XJ; Zong XL; Wu Q; Ren H; Ji JF
    World J Surg Oncol; 2011 Sep; 9():110. PubMed ID: 21942969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.